Home Your basket
• Papillary thyroid microca...
   Price 8.50 €
• Planned reconstruction af...
   Price 8.50 €
• Management of cerebellopo...
   Price 10.50 €
• A survey of current wound...
   Price 5.50 €
• The ENT in operations … T...
   Price 5.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• A study of peristomal rec...
   Price 5.50 €
• Airbag and hearing loss: ...
   Price 8.50 €
• Vibration induced nystagm...
   Price 10.50 €
• Early ENT manifestations ...
   Price 10.50 €
• Unilateral endolymphatic ...
   Price 10.50 €
• Acinic cell carcinoma in ...
   Price 8.50 €
• Clinical and histopatholo...
   Price 10.50 €
• Failure to regain full fu...
   Price 10.50 €
• Mycobacterial cervical ly...
   Price 10.50 €
• Mandibular reconstruction...
   Price 8.50 €
• Congenital bilateral choa...
   Price 5.50 €
• Pre-Congress of the Ameri...
   Price 8.50 €
• Proposition of adaptation...
   Price 10.50 €
• Which face lift for which...
   Price 14.00 €
• Phonatory threshold press...
   Price 10.50 €
• Two cases of primary mali...
   Price 8.50 €
• Evaluation of rhinologic ...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €
• Surgical anatomy of the f...
   Price 10.50 €
• Invasive cholesteatoma in...
   Price 10.50 €
• Cervical surgical emphyse...
   Price 5.50 €
• Comparison between extern...
   Price 10.50 €
• Malignant melanoma of the...
   Price 10.50 €
• Nasal cutaneous cryptococ...
   Price 5.50 €
• Neuroplasticity in the au...
   Price 10.50 €
• Mucosal melanomas of the ...
   Price 8.50 €
• Evaluation of quality of ...
   Price 10.50 €
• Cervico facial lymphangio...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Spontaneous subcutaneous ...
   Price 5.50 €
• Aneurysmal bone cyst of t...
   Price 5.50 €

Total Order 327.00 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 2 - 2016 o

OTOLOGY

Similarities between retina and cochlea: Anti-VEGF therapeutic perspectives


Authors : Papaxanthos M. (Bordeaux)

Ref. : Rev Laryngol Otol Rhinol. 2016;137,2:43-46.

Article published in english
Downloadable PDF document english



Summary : The physiopathology of cochlear microcirculation has been the object of many experimental recherch. The inability to measure cochlear blood flow in humans has limited the investi­ga­tion in animal models. The concepts, of brain, retina and labyrinth neurovascular units and brain, retina and labyrinth blood barrier, are today well admitted. The common physio­pathology of inner ear pathologies is the vascular barrier breakdown and up regulation of VEGF, Vascular Endothelial Growth Factor. Local treatment with anti-VEGF is now widely used in agis related macular degeneration (AMD). In conclu­sion, the author is convinced because of so many theoretical reasons explained briefly in this short article that anti-VEGF drugs may be the treatment revolution expected in inner ear pathologies. We believe that Anti-VEGF drugs should become in the near future the reference treatment for many inner ear diseases.

Price : 14.00 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE